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Summary  Successive  point-prevalence  surveys  were  conducted  annually  from  2007
to  2011  to  monitor  the  prevalence  of  healthcare-associated  infections  (HAIs)  in  a
university  hospital  in  Hubei  Province  in  China.  The  surveys  used  the  case  deﬁnition
criteria  established  by  the  Ministry  of  Health  of  the  People’s  Republic  of  China.  In
the  5  surveys,  the  overall  frequency  of  HAIs  was  3.16%  (301/9533).  No  signiﬁcant  dif-
ferences  were  identiﬁed  in  the  point  prevalence  measurements  of  HAIs  in  any  of  the
years  from  2007  to  2011.  Of  all  the  cases,  proportionally,  the  most  frequent  infection
site  was  the  respiratory  tract  (2.34%),  followed  by  surgical  sites  (0.43%)  and  urinary
tract  sites  (0.28%).  Gram-negative  aerobic  bacilli  were  the  most  common  organisms
mentioned;  the  most  frequently  isolated  organism  was  Pseudomonas  aeruginosa,
followed  by  Escherichia  coli  and  Acinetobacter  baumannii. Approximately  one-half
of  the  patients  were  receiving  antibiotics  at  the  time  of  the  surveys.  Cephalosporin,
penicillin,  and  quinolone  were  most  commonly  used  for  treatment  or  prevention.
The  differences  found  in  HAI  prevalence  data  across  the  5  surveys  given  in  the  hospi-
tal  were  not  statistically  signiﬁcant.  In  conclusion,  this  successive  point-prevalence
survey  provides  information  about  the  trend  of  HAI  prevalence,  epidemical  char-
acter,  and  the  use  of  antibiotics  among  the  university  hospital’s  in-patients.  This
information  allows  us  to  in
control.
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ealthcare-associated  infections  (HAIs)  are  associ-
ted with  prolonged  hospital  stays  and  increased
ealthcare costs  attributable  to  more  severe  dis-
ases [1,2].  Surveillance  is  an  essential  component
f any  comprehensive  program  for  reducing  HAIs
3,4].  Point-prevalence  surveys,  particularly  suc-
essive ones,  can  provide  a  snapshot  of HAI
revalence, including  infection  rates,  main  infec-
ion sites,  common  microorganisms,  and  the  use
f antibiotics  [5].  This  information  can  be  used
o establish  priorities  for  infection  prevention  and
ontrol and  to  function  as  a  tool  for  evaluating  an
AI situation.
From  2007  onward,  a  point-prevalence  survey
as conducted  annually  to  determine  the  charac-
eristics of  HAIs  in  Taihe  Hospital,  the  afﬁliated
ospital of  Hubei  University  of  Medicine  in  Shiyan
ity, Hubei  Province,  China.  Given  these  surveys,
e aimed  to  analyze  trends  of  HAI  prevalence,  epi-
emical  character,  and  the  use  of  antibiotics  among
n-patients  at  the  university  hospital.
ethods
ase deﬁnition
edical  records  were  reviewed  for  HAIs  using  the
eﬁnitions  established  by  the  Ministry  of  Health
f the  People’s  Republic  of  China,  which  were
odiﬁed from  the  case  deﬁnitions  of  the  National
osocomial Infection  Surveillance  System  (NISS)
6].  The  main  modiﬁcation  concerned  the  catego-
izations  of  respiratory  tract  infection  (RTI)  cases
nd the  case  deﬁnitions  of  patients  ≤12  months
f age.  In  Chinese  deﬁnitions,  the  deﬁnition  of  RTI
ncluded both  the  NISS  categories  of  ‘pneumonia’,
lower respiratory  tract  infection  other  than  pneu-
onia’,  and  ‘upper  respiratory  infection’,  which
as diagnosed  and  considered  an  HAI  only  if  the
atient  had  a  fever  higher  than  38 ◦C.  Otherwise,
atients ≤12  months  of  age  as  a  group  were  listed
ndependently  in  the  NISS  HAI  case  deﬁnitions,
hile patients  in  China  ≤12  months  of  age  were
ncluded in  the  general  criterion  for  HAI  diagno-
is, except  for  cardiovascular  system  infections  and
entral nervous  system  infections.
These infections  were  classiﬁed  into  7  groups:
TIs, urinary  tract  infections  (UTIs),  bloodstream
nfections (BSIs),  surgical  site  infections  (SSIs),  ali-
entary canal  infections  (ACIs,  including  infectious
iarrhea,  gastrointestinal  infection,  antibiotic-
ssociated diarrhea,  viral  hepatitis,  abdominal  or
s
t
s
dtion  surveys  in  a  university  hospital  in  China  417
elvic  tissue  infections,  and  ascites  infections),  skin
nd soft  tissue  infections  (STIs),  and  other  infec-
ions  (including  parotitis,  chickenpox,  nerve  system
nfections,  deep  organ  infections,  and  those  HAIs
ot included  in  the  aforesaid  cases).
According to  the  criteria,  an  infection  was  con-
idered an  HAI  if  it  was  diagnosed  48  h  or  more
fter admission,  provided  there  was  no  evidence
hat the  infection  was  sub-clinical  or  undiagnosed
t the  time  of  admission.  A  patient  was  also  con-
idered  an  HAI  case  if  he  or  she  was  still  receiving
reatment for  a HAI  and  no  longer  met  the  criteria
n the  day  of  survey.
tudy population
aihe  Hospital,  also  named  the  Afﬁliated  Hospi-
al of  Hubei  University  of  Medicine,  was  founded
n 1965  and  is  a  tertiary-stage  hospital  located  in
he City  of  Shiyan,  Hubei  Province  of  China.  There
ere 1477  beds  in  2007  and  2008,  1800  in  2009,
nd 2300  in  2010  and  2011  for  adults  and  children
n the  hospital,  with  50,853  admissions  in  2007,
5,563  in  2008,  61,056  in  2009,  70,421  in  2010,
nd 86,387  in  2011.  The  hospital  included  a  general
ntensive  care  unit  (ICU)  and  represented  all  medi-
al specialties.  We  divided  the  clinical  departments
nto the  following  5 groups:  departments  of  inter-
al medicine,  departments  of  surgery,  pediatrics,
CU, and  others  (consisting  of  Chinese  traditional
edicine, dentistry,  ENT  [ears,  nose,  and  throat]
edicine,  ophthalmology,  and  dermatology).  Point-
revalence  surveys  were  conducted  annually  in
ovember  from  2007  to  2011.  All  patients  in  the
ospital  who  had  been  hospitalized  for  at  least  48  h
t 8  a.m.  on  the  days  of  the  surveys  or  who  had  been
dmitted  in  the  past  7  days  were  registered  in  the
urveys.
ata collection
rom  2007  to  2011,  successive  HAI  point-prevalence
urveys were  performed  annually  in  the  hospital
sing the  same  methodology.  The  surveys  were
onducted  by  approximately  8 teams,  and  each
eam consisted  of an  infection  control  profes-
ional and  2—3  veteran  clinical  physicians.  Each
eam performed  HAI  surveys  on  3—5  wards  after  a
-day training  course  on  survey  skills.  Each  point-
revalence  survey  lasted  1—2  days.  During  each
urvey, team  members  visited  patients,  reviewed
heir medical  records,  and  ﬁnished  the  forms,  over-
een by  the  infection  control  professionals.  The
irector  of  the  department  of  hospital  infection
D.-s.  Xie  et  al.
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control  guided  all  surveys  and  was  also  responsible
for giving  methodological  assistance  when  needed.
Demographic and clinical data
Information  such  as  sex,  age,  present  diagnoses,
HAI status,  sites  of  infection,  results  of  microbio-
logical cultures,  and  antibiotic  treatments  received
were  recorded  for  each  patient.  The  survey  sought
information  on  risk  factors  and  clinical  features,
including the  presence  of  any  suspicious  infection
symptoms such  as  fever,  sputum,  coughing,  or  diar-
rhea, among  others,  along  with  pertinent  physical
examination  and  laboratory  data,  such  as  cultures,
chest  x-rays,  or  white  cell  blood  counts.  Every  in-
patient was  recorded  on  the  day  of  the  survey,  but
because  some  laboratory  results  were  unavailable
on the  day  of  the  survey,  the  team  would  follow  up
on the  reports  and  would  review  decisions  pertain-
ing to  the  infection  in  question.  The  purposes  of
the antibiotics  administered  were  classiﬁed  using
what the  physicians  wrote  in  the  patients’  charts.
In these  surveys,  antimicrobial  prophylaxis  was
deﬁned  as  giving  a  certain  amount  of  antibiotics  to
patients at  high  risk  of  infection  to  prevent  infec-
tion before  infections  actually  occurred.  The  entire
time reviewed  each  suspected  case  of  infection.
According to  the  case  records  and  the  patients’
symptoms, microorganism  reports  were  sorted  into
colonizers  or  pathogenic  bacteria  implicated  in
infections.  In  this  paper,  only  microorganisms  caus-
ing infection  were  reported;  no  colonizers  were
included.
Laboratory data
Organisms  were  identiﬁed  using  the  conventional
methods employed  locally.  If  microbial  culture
reports were  unavailable  on  the  day  of  the  survey,
the team  would  follow  up  on  the  reports  and  would
remake decisions  regarding  infection  status.
Data analyses
The  point-prevalence  of  infections  was  expressed
as the  total  number  of  HAIs  per  100  surveyed
patients who  had  been  either  hospitalized  for  at
least 48  h  or  admitted  in  the  previous  7 days,
with corresponding  95%  conﬁdence  intervals  (95%
CIs). The  control  cases  were  the  patients  with-
out HAIs.  Bartlett’s  Chi-squared  test  was  used
to evaluate  the  inequality  of  variances.  When
P < 0.05  (two-tailed),  variances  were  considered
non-homogeneous.  Logistic  regression  was  used  for
determining  the  risk  factors  independently  associ-
ated with  HAI.  Univariate  and  multivariate  logistic T
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Table  2  Prevalence  of  HAI  by  groups:  univariate  and  multivariate  analysis  (logistic  regression).
Class  (No.  of  patients)  Patients  with  HAI%  [95%CI]  OR  [95%CI]  Multivariate  ORa [95%  CI]
Categorization  of  present  diagnoses
Othersb (N  =  740)  1.22  [0.43—2.01]  1  1
Neoplasms  (N  =  1452)  3.65  [2.69—4.61]  3.08  [1.51—6.27],  P  =  0.001  2.95  [1.47—5.14],  P  =  0.001
Blood  and  blood-forming  organs
(N  =  169)
5.92  [2.36—9.47]  5.11[2.04—12.78],  P  <  0.001  5.13[2.07—12.70],  P  <  0.001
Endocrine,  nutritional  and
metabolic  diseases  (N  =  452)
2.43  [1.01—3.85] 2.03  [0.83—4.93],  P  =  0.112  2.13  [0.84—4.93],  P  =  0.151
Nervous  system  (N  =  536) 4.10  [2.42—5.78] 3.48  [1.59—7.61],  P  =  0.001 3.44  [1.51—7.67],  P  =  0.001
Circulatory  system  (N  =  1496) 3.21  [2.32—4.10] 2.69  [1.31—5.52],  P  =  0.005 2.79  [1.71—4.56],  P  =  0.003
Respiratory  system  (N  =  784) 3.83[2.48—5.17] 3.23  [1.52—6.85],  P  =  0.001 3.28  [1.57—5.96],  P  =  0.001
Digestive  system  (N  =  1524) 2.43[1.66—3.20] 2.02[0.97—4.21],  P  =  0.055 2.01  [0.98—4.20],  P  =  0.058
Genitourinary  system  (N  =  857) 1.75  [0.87—2.63] 1.45  [0.63—3.33],  P  =  0.382 1.48  [0.61—3.37],  P  =  0.350
Injury,  poisoning  and  certain
other  consequences  of  external
causes  (N  =  1523)
3.41  [2.50—4.33] 2.87  [1.41—5.86],  P  =  0.003 2.47  [1.30—5.44],  P  =  0.005
Sex
Female  (N  =  3514)  2.76  [2.22—3.30]  1  1
Male  (N  =  6019)  3.16  [2.72—3.60]  1.15  [0.90—1.47],  P  =  0.27  1.18  [0.91—1.48],  P  =  0.22
Age
14  years  (N  =  894) 2.80  [1.72—3.88]  2.05  [0.88—4.78],  P  =  0.09  2.60  [0.89—4.45],  P  =  0.17
15—24  years  (N  =  506) 1.38[0.37—2.40] 1  1
25—44  years  (N  =  1656) 1.81  [1.17—2.45]  1.32  [0.57—3.01],  P  =  0.516  1.31  [0.52—2.97],  P  =  0.451
45—64  years  (N  =  3638) 3.16  [2.59—3.73-]  2.33  [1.08—5.02],  P  =  0.027  2.34  [1.08—5.12],  P  =  0.021
65—74  years  (N  =  2097) 3.43  [2.65—4.21]  2.53[1.16—5.54],  P  =  0.016  2.58  [1.46—5.85],  P  =  0.022
≥75years  (N  =  742)  5.12  [3.54—6.71]  3.85  [1.70—8.69],  P  <  0.001  3.96  [1.80—8.88],  P  <  0.001
Hospital  area
Othersc (N  =  1287)  1.24  [0.64—1.85]  1  1
Departments  of  internal
medicine  (N  =  3188)
3.89 [3.22—4.56]  3.21  [1.90—5.43],  P  <  0.001  2.82  [1.56—4.37],  P  <  0.001
Departments  of  surgery
(N  =  4211)
2.49  [2.02—2.96]  2.03  [1.20—3.45],  P  =  0.008  1.76  [1.11—3.03],  P  =  0.008
Departments  of  pediatrics
(N  =  756)
2.51  [1.40—3.63] 2.05  [1.05—4.01],  P  =  0.033  1.54  [0.98—2.54],  P  =  0.075
Intensive  care  units  (N  =  91) 25.27  [16.35—34.20]  26.87  [13.57—53.20],  P  <  0.001  15.87  [8.52—37.44],  P  =  0.002
OR, odds ratio; CI, conﬁdence interval.
a Adjusted for all variables on the model.
b Refers to all admission diagnoses not included in the listed categories.
c Refers to departments of Chinese traditional medicine, dentistry, ENT [ears, nose and throat] medicine, ophthalmology, and dermatology.
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regression  analyses  were  performed  to  identify  the
risk factors  for  HAI.  Risk  was  expressed  as  crude  and
as adjusted  odds  ratios  (ORs)  with  95%  conﬁdence
intervals (CIs).  Statistical  analysis  was  performed
using SAS,  version  8.2  (SAS  Institute  Inc,  Cary,  NC).
Differences  in  proportions  of  HAIs  (with  95%  CI)  in
the successive  study  periods  were  determined.
Results
Prevalence and infection sites
In total,  9533  patients  were  included  in  the  sur-
veys from  2007  to  2011.  Of  these  patients,  63.14%
were  male,  with  a  mean  age  of  43.10  years  (ranged
from 1  day  to  91  years).  There  were  287  patients
with HAIs,  with  an  overall  prevalence  of  3.16  HAIs
per 100  patients  (301/9533,  95%  CI,  2.81—3.51).
The overall  rates  of  HAIs  in  our  study  ranged  from
2.85% to  3.43%  according  to  year.  There  was  no  sig-
niﬁcant difference  between  the  overall  prevalence
of HAIs  and  HAIs  from  2007  to  2011  (2 =  1.153,
p =  0.886).  Proportionally,  RTIs  were  the  most  com-
mon infections  (223  cases  [74.09%]),  followed  by
UTIs (27  cases  [8.97%]),  SSIs  (18  cases  [5.98%]),  and
ACIs (18  cases  [5.98%]).  In  the  successive  5  surveys,
47.83%  (4560/9533)  of  the  patients  received  antibi-
otics (Table  1).
Risk factors
The  distributions  of  HAIs  varied  among  different
diseases. Patients  with  blood-based  diseases  or  dis-
ease in  organs  involved  in  producing  blood  had  the
highest prevalence  of  HAIs  (10/169,  5.92%),  fol-
lowed by  patients  with  diseases  of  the  nervous
system (22/536,  4.10%)  and  with  diseases  of  the
respiratory  system  (30/784,  3.83%).  The  prevalence
of patients  older  than  75  years  with  HAIs  was  higher
(38/742,  5.12%)  than  the  other  age  brackets.  The
prevalence  of  HAIs  developing  in  patients  in  ICUs
(23/91,  25.27%)  was  higher  than  that  of  HAIs  in
patients  in  other  departments.  The  risk  factors  for
HAIs, along  with  their  univariate  ORs  and  multivari-
ate ORs,  are  shown  in  Table  2.  In the  multivariate
analysis, statistically  signiﬁcant  associations  were
identiﬁed  for  the  following  factors:  categorization
of present  diagnoses,  age,  and  type  of  hospital
area.Microorganisms discovered
In these  surveys,  most  HAI  episodes  were  diag-
nosed by  physical  symptoms  and  radiographs,
r
t
[
(D.-s.  Xie  et  al.
ith  only  42.19%  (127/301)  receiving  positive  test
esults and  only  135  pathogenic  bacteria  types
eing isolated.  Gram-negative  bacteria  were  iso-
ated most  frequently.  Overall,  the  most  commonly
solated organism  was  Pseudomonas  aeruginosa,
ollowed by  Escherichia  coli,  Acinetobacter  bau-
annii, and  Staphylococcus  aureus.  In  RTI  patients,
. aeruginosa  and  A.  baumannii  were  the  most
ommonly isolated  pathogens,  followed  by  fungi,
articularly  Candida  albicans. In  patients  with
SIs, S.  aureus  were  the  most  common  pathogens,
ollowed by  Klebsiella  pneumoniae. Fungi  and
. coli  were  the  most  common  pathogens  for  UTIs
Table  3).
ntibiotic use
f  the  patients  included  in  these  surveys,  47.83%
ere receiving  antimicrobial  treatment  on  the  sur-
ey days.  The  highest  rate  was  57.18%  in  2008,  and
he lowest  rate  was  43.63%  in  2011;  the  difference
as statistically  signiﬁcant  from  2007  to  2011.  Of
hese patients,  3001  (65.80%)  patients  used  one
ntibiotic,  1486  (32.59%)  patients  took  two,  and  73
1.61%) patients  took  three  or  more  than  three.  The
ollowing  antibiotics  were  the  most  commonly  used
or treatment  or  prevention:  cephalosporin  (2645
58.00%]),  penicillin  (1048  [22.98%]),  and  quinolone
638 [13.99%]).  Cephalosporin  and  penicillin  were
he antibiotics  most  frequently  used  in  the  ICU,  and
ephalosporin  was  the  most  frequently  used  antibi-
tic in  medical,  surgical,  and  pediatric  wards.
iscussion
he  surveillance  of  HAIs  is  important  for  justifying
he implementation  and  subsequent  evaluation  of
nfection prevention  and  control  policies  and  meas-
res [7—9]. Moreover,  monitoring  HAIs  is  of  great
igniﬁcance for  establishing  prevention  measures.
he 5  successive  point-prevalence  surveys  may  be
he most  accurate  approach  to  obtain  HAI  data,
onsidering the  extensive  labor,  time,  and  ﬁnancial
esources  required  [3,4,10]. Among  patients,  the
istributions  of  infections  varied  by  diseases,  gen-
ers, age,  and  hospital  departments.  The  results
ndicated  that  the  differences  in  HAI  prevalence  in
he 5  surveys  in  the  hospital  were  statistically  non-
igniﬁcant  and  that  the  overall  prevalence  of  HAIs  in
he hospital  was  3.16%,  which  was  lower  than  that
eported  in  other  studies  in  Hubei  (4.14%)  [12],  in
he nationwide  survey  conducted  in  China  (4.77%)
13]  and  in  surveys  conducted  in  other  countries
5.1—16.8%) [3,11,14—16].  In  contrast  to  studies  in
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Table  3  Distribution  of  pathogens  in  a  University  Hospital  in  China.
Pathogen  No.  of  pathogens  (%),  by  infection  sites  Total
RTI  SSI  UTI  ACI  Others
Gram-negative  bacteria  73  11  2  2 2  90
Pseudomonas  aeruginosa 27  2  0  1 0  30
Escherichia  coli 10  2  2  1 2  17
Klebsiella  pneunoniae  8  5  0  0 0  13
Acinetobacter  baumannii  17  0  0  0 0  17
Pseudomonas  maltophilia  6  0  0  0 0  6
Others  5  2  0  0 0  7
Gram-positive  bacteria  12  10  1  1 0  24
Staphylococcus  aureus  7  6  0  0 0  13
Enterococcus  spp.  0  2  1  1 0  4
Streptococcus  2  2  0  0 0  4
Others  3  0  0  0 0  3
Fungus  11  0  3  0 0  14
Candida  albicans  8  0  1  0 0  9
Others  3  0  2  0 0  5
Others  2  2  1  1 1  7
Total  98  23  7  4 3  135
RTI, respiratory tract infections; SSI, surgical site infections; UTI, urinary tract infections; ACI, alimentary canal infections; Other
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Cinfections, including bloodstream infections, skin and soft tiss
those HAI not included in aforesaid cases.
ther  countries  that  implicated  UTIs  as  the  most
ommon  HAIs  [14,15], we  found  that  the  respira-
ory tract  was  the  most  frequent  HAI  site,  which
as consistent  with  the  results  of  other  studies  in
hina, Greece,  and  Italy  [3,12,13,16]. The  differ-
nces between  the  prevalence  data  reported  by
ome publications  and  our  survey  may  be  explained
y the  differing  average  lengths  of  stay,  deﬁnitions
f clinical  conditions  used,  areas,  sizes  of  hospitals,
nd surveillance  methods  performed  for  measuring
AIs [17].
Gram-negative  bacteria  were  more  commonly
solated than  were  Gram-positive  bacteria  in  our
tudy, which  is  in  accordance  with  reports  from
ther studies  [3,12,13,18]. The  overall  prevalence
f patients  receiving  antibiotics  treatment  was
7.83%. In  our  2011  survey,  the  prevalence  dropped
o 43.63%,  which  was  likely  the  result  of  antibi-
tic management  policies  initiated  by  the  Ministry
f Health  throughout  the  country.  The  new  poli-
ies began  in  May  of  2011  and  banned  antibiotics
veruse and  reduced  antibiotics  consumption.  The
ncreasingly  stringent  policies  regarding  antimi-
robial  drug  use  included  tight  restrictions  on
ntimicrobial  use  conditions  and  restrictions  on
eﬁned daily  dose  (DDD)  values  under  40,  limited
ntibacterial  drug  varieties  to  fewer  than  60  in hospital,  and  severed  economic  connections
etween pharmaceutical  companies  and  doctors.
he impact  of  this  policy  on  HAI  prevalence  is  not
et clear;  we  need  more  time  to  make  observations.
Ffections, nerve system infections, deep organ infections, and
In  the  5  surveys  of  patients  using  antibiotics,
1.89% of  cases  were  attributed  to  prophylaxis.
n a European  surveillance  of  antimicrobial  con-
umption  in  20  hospitals,  30.1%  of  in-patients  were
eceiving  antibacterial  treatment  on  the  day  of  the
urvey [19].  Antibiotic  resistance  has  become  an
mportant  public  health  issue  worldwide,  includ-
ng in  China,  and  it  is  crucial  for  all  medical  staff
o be  aware  of  the  relationship  between  antibiotic
onsumption and  the  emergence  of  resistance.
Regrettably,  due  to  constraints  of  time  and  per-
onnel,  not  all  factors  potentially  associated  with
AIs were  considered  in  the  study  design.
onclusion
n  conclusion,  the  current  successive  point-
revalence survey  yields  data  on  the  trend  of  HAI
revalence,  epidemical  character,  and  the  use  of
ntibiotics among  in-patients  in  a university  hos-
ital. With  this  data,  we  can  initiate  targeted
rograms of infection  prevention  and  control.
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